Latest filing published 29 Jan 2021 for Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.), €689.
This profile gathers the share dealings of Cheryl Farmer in Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.). Between 23 December 2015 and 29 January 2021, the trades on record add up to 31 filings.
No open-market sale appears; the market trades are 28 purchases worth €43k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2021 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €652. The 13 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 29 January 2021 with an open-market purchase (€689) in Lattice Biologics Ltd. (formerly Blackstone Ventures Inc.). Half of the filings or more reach the SEDI feed on the day of the trade. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations